Subgroup | Number of studies | Estimates | Heterogeneity | |||
---|---|---|---|---|---|---|
Prevalence (%) | 95% CI | I2 (%) | Q(DF) | P-value | ||
Country | ||||||
 Ethiopia | 3 | 27.7 | 21.42, 34.05 | 96.8 | 195.17(2) | < 0.001 |
 Nigeria | 9 | 25.3 | 18.68,31.88 | 97.8 | 237.2(8) | < 0.001 |
 Uganda | 3 | 9.80 | 7.86, 11.78 | 92.7 | 157.9(2) | < 0.001 |
 South Africa | 4 | 18.05 | 7.13, 28.97 | 96 | 186.23(3) | < 0.001 |
Study design used | ||||||
 Cross-sectional | 16 | 21.60 | 16.19, 27.05 | 98.6 | 521.57(15) | < 0.001 |
 Cohort and case control | 3 | 22.20 | 8.48, 35.92 | 98.8 | 632.56(2) | < 0.001 |
Sample size studied | ||||||
 < 400 | 13 | 23.42 | 18.12, 28.72 | 98.4 | 498.12(12) | < 0.001 |
 ≥ 400 | 6 | 18.30 | 8.87, 27.16 | 96.2 | 235.05(5) | < 0.001 |
Assessment tool used | ||||||
 MINI | 10 | 16.96 | 8.97, 24.95 | 94.6 | 158.32(9) | < 0.001 |
 CIDI | 4 | 27.70 | 21.42, 34.05 | 96.8 | 195.17(2) | < 0.001 |
 BDI and PHQ-9 | 5 | 25.00 | 14.86, 35.14 | 94.2 | 165.20(4) | < 0.001 |
Year of publication | ||||||
 After 2015 | 8 | 24.65 | 17.47, 31.83 | 87 | 96.3(7) | < 0.001 |
 Before and in 2015 | 11 | 19.57 | 12.20, 26.95 | 92 | 128.5(10) | < 0.001 |